Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Werte in diesem Artikel
Financial release accessible online
BOSTON, Feb. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 6, 2025. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BIda08929a4d56464eb33eccb945ef985e
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/63jte4ra
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 3Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/36134646-a371-4076-87b9-26673f9f10f3
A replay of the conference call and webcast will be available for one year beginning on February 6, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302368961.html
SOURCE Haemonetics Corporation
Ausgewählte Hebelprodukte auf Haemonetics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Haemonetics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Haemonetics Corp.
Analysen zu Haemonetics Corp.
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2017 | Haemonetics Mkt Perform | Barrington Research | |
07.11.2016 | Haemonetics Hold | The Benchmark Company | |
11.05.2016 | Haemonetics Hold | The Benchmark Company | |
05.11.2015 | Haemonetics Hold | The Benchmark Company | |
16.08.2006 | Update Haemonetics Corp.: Hold | Stanford Research |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen